{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-103843","form_type":"8-K","ticker":"NERV","cik":"0001598646","company_name":"Minerva Neurosciences, Inc.","filed_at":"2022-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.382742+00:00","generated_at":"2026-06-26T07:40:59.363353+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Minerva Neurosciences hosts roluperidone update webcast; no specific details in 8-K","bullets":["Company held an investor webcast on April 13, 2022, to discuss updates on roluperidone.","The 8-K filing includes only a cover page and dial-in information for the webcast.","No clinical data, regulatory milestones, or financial guidance were disclosed in the filing.","Investors must access the webcast replay or presentation to learn the actual update content."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-103843","json":"https://secwatch.observer/filing/0001193125-22-103843.json","markdown":"https://secwatch.observer/filing/0001193125-22-103843.md","text":"https://secwatch.observer/filing/0001193125-22-103843.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522103843/0001193125-22-103843-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522103843/d333769d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T07:40:59.363353+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}